Evidence map›Paper›PMID 32440113›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2020

Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Jesús Recio Iglesias, Jesús Díez-Manglano, Francisco López García, José Antonio Díaz Peromingo, Pere Almagro, José Manuel Varela Aguilar

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Loss of muscle and bone mass with increased adiposity and fractures in patients with chronic obstructive pulmonary disease: A 5-year follow-up cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Observational
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. 20-year trends in excess costs of COPD.The European respiratory journal · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review.International journal of chronic obstructive pulmonary disease · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jesús Recio IglesiasInternal Medicine Department, Quironsalud Valencia Hospital, Valencia, Valencian Community, Spain.ORCID 0000-0001-8640-9015
Jesús Díez-ManglanoInternal Medicine Department, Royo Villanova Hospital, Zaragoza, Aragon, Spain.
Francisco López GarcíaInternal Medicine Department General University Hospital of Elche, Alicante, Valencian Community, Spain.
José Antonio Díaz PeromingoInternal Medicine Department, University Clinical Hospital of Santiago de Compostela, a Coruña, Galicia, Spain.ORCID 0000-0002-5784-8737
Pere AlmagroInternal Medicine Department, Mútua Terrassa University Hospital, Terrassa, Barcelona, Catalonia, Spain.ORCID 0000-0002-8476-4942
José Manuel Varela AguilarInternal Medicine Department, University Hospital Virgen del Rocío, Seville, Andalusia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is associated with multiple comorbidities, which impact negatively on patients and are often underdiagnosed, thus lacking a proper management due to the absence of clear guidelines. Purpose: To elaborate expert recommendations aimed to help healthcare professionals to provide the right care for treating COPD patients with comorbidities. Methods: A modified RAND-UCLA appropriateness method consisting of nominal groups to draw up consensus recommendations (6 Spanish experts) and 2-Delphi rounds to validate them (23 Spanish experts) was performed. Results: A panel of Spanish internal medicine experts reached consensus on 73 recommendations and 81 conclusions on the clinical consequences of the presence of comorbidities. In general, the experts reached consensus on the issues raised with regard to cardiovascular comorbidity and metabolic disorders. Consensus was reached on the use of selective serotonin reuptake inhibitors in cases of depression and the usefulness of referring patients with anxiety to respiratory rehabilitation programmes. The results also showed consensus on the usefulness of investigating the quality of sleep, the treatment of pain with opioids and the evaluation of osteoporosis by lateral chest radiography. Conclusion: This study provides conclusions and recommendations that are intended to improve the management of the complexity of patients with COPD and important comorbidities, usually excluded from clinical trials.

Indexed as

Pulmonary Disease, Chronic ObstructiveAnxietyComorbidityConsensusHealth ServicesHumanschronic obstructive pulmonary diseasecomorbiditiesCOPDDelphi techniquemodified RAND-UCLA

Identifiers

PMID32440113
PMCPMC7217705

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.